5 results match your criteria: "University Cruces Hospital[Affiliation]"

The neurological phenotype of 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) and short-chain enoyl-CoA hydratase (SCEH) defects is expanding and natural history studies are necessary to improve clinical management. From 42 patients with Leigh syndrome studied by massive parallel sequencing, we identified five patients with SCEH and HIBCH deficiency. Fourteen additional patients were recruited through collaborations with other centres.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the potential of asymmetric dimethylarginine (ADMA) as a biomarker for monitoring metabolic control and nutritional risks in patients with Phenylketonuria (PKU) who follow a low-protein diet.
  • In a cross-sectional analysis of 106 PKU patients compared to a control group, results showed significantly lower levels of ADMA, symmetric dimethylarginine (SDMA), and arginine in PKU patients, alongside correlations between ADMA and phenylalanine levels.
  • The findings suggest that the ADMA/creatinine ratio could be an independent and reliable biomarker for PKU management, helping identify dietary imbalances that might pose long-term health risks.
View Article and Find Full Text PDF

Unlabelled: Fractures at the proximal metaphyso-diaphyseal junction of the fifth metatarsal are associated with high rates of delayed union. When these fractures are the result of repeated stress in patients with equinovarus hindfoot, which in turn is caused by neurological disorders, delayed union is the rule. Therefore, in neurological patients with stress fractures, optimal treatment would be to achieve a plantigrade foot enabling them to relieve the fifth metatarsal overload, which prevents the consolidation.

View Article and Find Full Text PDF

Nutritional management of very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is based on the avoidance of fasting and substitution of medium-chain triglycerides for long- and very long-chain triglycerides. We report two cases of this disease, which developed omega-6 essential fatty acid deficiency after three and five months from the beginning of nutritional therapy (SHS product: Monogen). This alteration could be especially dangerous in these patients owing to their possible susceptibility to the development of pigmentary retinopathy.

View Article and Find Full Text PDF